Quick Answer
Stemtech Corp reported Total Revenue of $5.05 million for fiscal year 2024.
Stemtech Corp — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | $5.05M +2.7% |
$4.92M +7.9% |
$4.56M +5.5% |
$4.32M -1.4% |
$4.38M | — |
| Revenue (ASC 606) | $5.05M +2.7% |
$4.92M +7.9% |
$4.56M +5.5% |
$4.32M -1.4% |
$4.38M | — |
| Net Income | -$3.77M +30.6% |
-$5.43M +36.5% |
-$8.54M -20.7% |
-$7.08M -20484.8% |
-$34.4K -1.6% |
-$33.8K +9.2% |
| Diluted EPS | -$0.03 +57.1% |
-$0.07 +63.2% |
-$0.19 +5.0% |
-$0.20 -100.0% |
-$0.10 | — |
| Total Assets | $3.78M +2.7% |
$3.68M -13.7% |
$4.27M -25.4% |
$5.72M +12217.8% |
$46.4K +1496.9% |
$2.9K -80.4% |
| Cash and Equivalents | — | — | $132.5K -84.0% |
$828.2K +37156.2% |
$2.2K +211.3% |
$714.00 -91.3% |
| Stockholders Equity | -$4.48M -119.9% |
-$2.04M +16.2% |
-$2.43M +27.5% |
-$3.36M -1386.2% |
-$225.8K -18.0% |
-$191.4K -21.5% |
| R&D Expense | — | $13.8K | $0.00 | — | $750.00 | — |
| Operating Income | -$2.39M +43.5% |
-$4.22M +15.9% |
-$5.02M -56.5% |
-$3.21M -16891.0% |
-$18.9K +6.2% |
-$20.1K +18.8% |
| Gross Profit | $3.73M -4.9% |
$3.92M +15.4% |
$3.40M +3.0% |
$3.30M -10.1% |
$3.67M | — |
| Shares Outstanding | 135.76M +29.3% |
104.99M +96.5% |
53.44M +19.6% |
44.69M +30.5% |
34.25M | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $852.3K | -17.4% | +22.1% |
| Revenue (ASC 606) | September 30, 2025 | $852.3K | -17.4% | +22.1% |
| Net Income | September 30, 2025 | -$809.4K | +30.8% | -176.1% |
| Diluted EPS | September 30, 2025 | -$0.01 | +0.0% | — |
| Total Assets | September 30, 2025 | $3.76M | — | -3.0% |
| Cash and Equivalents | March 31, 2023 | $343.3K | -32.8% | +159.1% |
| Stockholders Equity | September 30, 2025 | -$5.80M | — | -1.7% |
| R&D Expense | September 30, 2025 | $0.00 | — | — |
| Operating Income | September 30, 2025 | -$339.2K | +52.7% | -12.7% |
| Gross Profit | September 30, 2025 | $682.5K | +4.8% | +23.6% |
| Shares Outstanding | September 30, 2025 | 158.89M | — | +11.5% |
- Stemtech Corp reported Total Revenue of $5.05 million for fiscal year 2024.
- Stemtech Corp showed an increase of +2.7% in Total Revenue compared to the prior fiscal year.
- Stemtech Corp reported Revenue (ASC 606) of $5.05 million for fiscal year 2024.
- Stemtech Corp showed an increase of +2.7% in Revenue (ASC 606) compared to the prior fiscal year.
- Stemtech Corp reported Net Income of -$3.77 million for fiscal year 2024.
- Stemtech Corp showed an increase of +30.6% in Net Income compared to the prior fiscal year.
- Stemtech Corp reported Diluted EPS of $0.03 per share (loss) for fiscal year 2024.
- Stemtech Corp showed an increase of +57.1% in Diluted EPS compared to the prior fiscal year.
- Stemtech Corp reported Total Assets of $3.78 million for fiscal year 2024.
- Stemtech Corp showed an increase of +2.7% in Total Assets compared to the prior fiscal year.
- Stemtech Corp reported Cash and Equivalents of $132.5 thousand for fiscal year 2022.
- Stemtech Corp showed a decrease of -84.0% in Cash and Equivalents compared to the prior fiscal year.
- Stemtech Corp reported Stockholders Equity of -$4.48 million for fiscal year 2024.
- Stemtech Corp showed a decrease of -119.9% in Stockholders Equity compared to the prior fiscal year.
- Stemtech Corp reported R&D Expense of $13.8 thousand for fiscal year 2023.
- Stemtech Corp reported Operating Income of -$2.39 million for fiscal year 2024.
- Stemtech Corp showed an increase of +43.5% in Operating Income compared to the prior fiscal year.
- Stemtech Corp reported Gross Profit of $3.73 million for fiscal year 2024.
- Stemtech Corp showed a decrease of -4.9% in Gross Profit compared to the prior fiscal year.
- Stemtech Corp reported Shares Outstanding of 135.76 million shares for fiscal year 2024.
- Stemtech Corp showed an increase of +29.3% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: